Business / Finance

RSS

Pittcon’s first San Antonio experience a roaring success

Pittcon, the nation’s premier annual conference and exposition on laboratory science, is pleased to announce that the 77th Annual Pittcon, held in San Antonio, Texas, on March 7-11, 2026, was an enormous success.

From Pittcon 24 Mar 2026

LGM Pharma expands U.S. manufacturing, bringing total investment to $15M across Texas and Colorado sites

LGM Pharma, a leading provider of tailored API sourcing, contract analytical testing, and CDMO services for the full drug product lifecycle, today announced the second phase of its CDMO growth strategy, committing an additional $9 million to its facilities in Rosenberg, Texas, and Colorado Springs, Colorado.

From LGM Pharma 19 Mar 2026

DNA Script expands global access to on-demand DNA synthesis with distributor agreements in Latin America and East Asia

DNA Script, a pioneer in DNA synthesis providing scientists with rapid, on-demand access to high-quality DNA, today announced it has signed distribution agreements with Gencell, Bio-Medical Science Co. (BMS), and BioStream Co., expanding global access to the Company's SYNTAX® platform for decentralized, in-house and on-demand oligonucleotide production.

From DNA Script 18 Mar 2026

Abselion establishes US subsidiary in Cambridge, MA

Abselion, a pioneering life sciences technology company focused on simplifying biomolecule quantification, today announced that it has established a US subsidiary at The Engine in Cambridge, MA.

9 Mar 2026

LGB+ NHS workers who disclose their identity tend to earn more

This study examines pay dynamics in the NHS, revealing that LGB+ identity disclosure is linked to higher earnings, emphasizing the need for inclusive policies.

9 Mar 2026

Azenta enters definitive agreement for the sale of its B Medical Systems business to THELEMA S.À R.L.

Azenta, Inc. today announced that its affiliate, Azenta Germany GmbH, has signed a binding agreement for the sale of Azenta’s B Medical Systems business to THELEMA S.À R.L., for a purchase price of US$63 million.

From B Medical Systems S.à r.l 2 Mar 2026

Danaher to acquire Masimo Corporation

Danaher Corporation, a global science and technology innovator, announced today that it has entered into a definitive agreement to acquire Masimo Corporation a leading specialty diagnostics provider of pulse oximetry and other patient monitoring solutions, primarily in acute care settings.

From Danaher Life Sciences 24 Feb 2026

TRIMTECH Therapeutics appoints Alison Lawton as Chair of the Board

TRIMTECH Therapeutics, a biotechnology company developing novel small molecule therapies that target and degrade protein aggregates associated with neurodegenerative diseases, today announced the appointment of Alison Lawton as Chair of its Board of Directors.

From TRIMTECH Therapeutics 4 Dec 2025

TRIMTECH Therapeutics appoints Dr Mike Hutton to Scientific Advisory Board

TRIMTECH Therapeutics, a biotech company creating novel, small molecule therapeutics that selectively degrade protein aggregates, to combat neurodegenerative diseases, today announced the appointment of Dr Mike Hutton to its Scientific Advisory Board (SAB).

From TRIMTECH Therapeutics 12 Nov 2025

Yokogawa announces YNOW2026 Users Conference dates

Yokogawa Corporation of America is pleased to confirm the dates for the next Yokogawa Users Conference and Exhibition, YNOW2026, taking place in New Orleans, Louisiana, September 1–3, 2026.

21 Oct 2025

AZoNetwork joins CPD Certification Service, offering accreditation to attendees of digital scientific events

AZoNetwork, a leading digital marketing platform for science, healthcare, and engineering companies, has recently obtained membership in the CPD Certification Service.

10 Oct 2025

TRIMTECH Therapeutics establishes Scientific Advisory Board

From TRIMTECH Therapeutics 3 Sep 2025

DIVA celebrates 30th anniversary with three milestone product launches and new website debut

DIVA, a professional medical display manufacturer with 30 years of experience, announces three major product developments that reinforce its commitment to high-performance imaging solutions.

From DIVA Labs 13 Aug 2025

EVIDENT to Acquire Pramana, Inc.

Evident announces a definitive agreement to acquire Pramana, Inc., a leading manufacturer of digital pathology solutions.

13 Aug 2025

Monmouth Scientific launches refreshed brand and new website

The updated Monmouth Scientific website enhances user experience, offering tailored clean air solutions and technical resources for the life science sector.

From Monmouth Scientific 29 Jul 2025

How funding influences cardiac red meat study conclusions

A review reveals how industry funding influences red meat studies, highlighting the need for transparent nutrition research on cardiovascular health impacts.

16 Jun 2025

Enhanced Genomics appoints Dietrich Stephan, Ph.D. as Chair of the Board to lead ambitious growth strategy

Enhanced Genomics (‘Enhanced’ or ‘the Company’), the biotechnology company pioneering 3D multi-omics to rapidly identify high-confidence, genetically validated drug targets for common diseases, today announced the appointment of Dietrich Stephan, Ph.D. as Chair of the Board of Directors.

11 Jun 2025

Sapio Sciences appoints Gordon McCall as Chief Operating Officer to drive global operational excellence

Sapio Sciences, the science-aware™ lab informatics platform, today announced the promotion of Gordon McCall to Chief Operating Officer (COO).

From Sapio Sciences 28 May 2025

Closed Loop Medicine appoints Kate Woolland as CEO

Closed Loop Medicine Ltd. (“CLM”), a leader in pharmaceutical precision dosing, today announced the appointment of Kate Woolland as Chief Executive Officer.

22 May 2025

Trilobio raises $8M to deliver whole lab automation for biologists

Trilobio, the Company building the fully automated robotic lab-in-a-box for biologists, today announced it has raised $8 million USD Seed investment. The oversubscribed round was led by Initialized Capital, including participation from Argon Ventures and Lowercarbon Capital.

From Trilobio 12 May 2025